Technology News & Search Engine

Home: Technology News: Latest Research Report on Cell based Assay Market with its Key Opportunities and Business Challenges   (IT-NEWSWIRE.COM, October 23, 2019 ) The cell based assay market is projected to reach USD 18.9 billion by 2024 from USD 13.9 billion in 2019, at a CAGR of 6.3%. The growth of this market is majorly driven by the growing preference for cell-based assays, increasing research funding, and the growth in the number of drug discovery activities. However, the high cost of instruments and restrictions on reagent use are the major factors restraining the growth of this market. The cell-based assays market is segmented into consumables, instruments, and services. The consumables segment accounted for majority of the market share in 2019 and is anticipated to grow at a CAGR of 6.6% during the forecast period. This growth can be attributed to the increasing number of drug discovery activities, especially in emerging markets. Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=119917269 The cell-based assays market is segmented into drug discovery, basic research and other applications such as quality check among others. The drug discovery segment is anticipated to drive growth in the market at a CAGR of 7.5% over the forecast period. This growth can be attributed to the increase in R&D investment by biopharmaceutical companies. North America commanded the largest share in the cell-based assays market. The large share of North America in this market can be attributed to the increasing R&D activities by biopharma companies and increasing presence of these companies in the US is expected to increase the demand for cell-based assays product and services in this region. View complete press release:- https://www.marketsandmarkets.com/PressReleases/cell-based-assays.asp Some of the major players in this market include Thermo Fisher Scientific, Inc. (US), Danaher Corporation (Beckman Coulter, Inc.) (US), Becton, Dickinson and Company (US), GE Healthcare (US), Merck KGaA (Germany), Lonza Group (Switzerland), PerkinElmer, Inc. (US), Charles River Laboratories, Inc. (US), Cell Signaling Technologies (US), Cisbio (US), Cell Biolabs, Inc. (US), and Promega Corporation (US). 360Quadrants Mr. Shelly Singh 1-888-600-6441 raviraj.tak@marketsandmarkets.com Source: EmailWire.Com Source: EmailWire.com

Sponsored Links EmailWire Business Directory EmailWire Business Directory about Legal, Stocks, Investment, Markets, Stocks Submit website to Business Directory

Technology News Headlines Computer Security Digital Music Digital Video/TV Enterprise Linux/Open Source Microsoft Mobil Phones Internet Personal Technology Portals & Search Engines RSS and Blogging Software Technology News

GroupWeb Market Place Website Builder - Blog Builder Build your website in 5 minutes. One month free. No setup fee! Blog Included. WebSiteBuilder.GroupWeb.Com Your text Ads here! Ads are only $50 per month.Please contac us and state ou want to place advertisement on GroupWeb.com. Emailwire.com/contact.php